Corporate ActionJul 29, 2026, 05:06 PM
OS Therapies Terminates $18M At-The-Market Equity Offering
AI Summary
OS Therapies Inc. has terminated its At Market Issuance Sales Agreement with B. Riley Securities, Inc. and JonesTrading Institutional Services LLC, effective July 28, 2026. This agreement, established on August 8, 2025, allowed the company to sell up to $18,000,000 of its common stock. Prior to termination, OS Therapies had sold 282,679 shares, generating approximately $530,162 in gross proceeds, with $17,469,838 remaining unsold. No termination fees were incurred by either party.
Key Highlights
- OS Therapies terminated its At Market Issuance Sales Agreement with B. Riley Securities and JonesTrading Institutional Services.
- The agreement, dated August 8, 2025, allowed the company to offer and sell up to $18,000,000 of common stock.
- The termination became effective on July 28, 2026.
- The company had sold 282,679 shares for approximately $530,162 under the agreement.
- Approximately $17,469,838 of common stock remained unsold at the time of termination.
- No termination fees or other payments were due by either party.
Price Impact
More from OSTX